The Shawview Report, commissioned by Johnson & Johnson, is a valuable, timely round-up of the inherent problems in our medicines funding system and offers some good solutions, including innovative funding mechanisms in action in other countries, as well as the immediate need to fund Pharmac’s current backlog of approved medicines waiting for funding.
If you’re contemplating taking a proactive approach to establish connections with politicians before the upcoming election, with the aim of advocating for issues related to Multiple Myeloma, including the deficiency of new medications and treatment protocols, these resources – the report and the interview featuring Brendan Shaw – represent invaluable tools to help assist you in this process.
Listen to the RNZ interview here: RNZ Shawview report interview
Here is the report
Here are other ways to get involved: https://www.multiplemyeloma.org.nz/get-involved/